Show document

A+ | A- | | SLO | ENG

Title: Izbira pretvornika signalov za laboratorijske potrebe Authors: ID Krajnik, Domen (Author) ID Kocijan, Juš (Mentor) More about this mentor... Files: http://www.ung.si/~library/diplome/PTF/84Krajnik.pdf   84Krajnik.pdf (1,03 MB) MD5: F6808BA8CCA6E26B42A7350397C7411A   Language: Slovenian Work type: Undergraduate thesis Typology: 2.11 - Undergraduate Thesis Organization: PTF - Faculty of Engineering and Management Keywords: diplomske naloge, signali, pretvorniki, avtomatski regulacijski sistemi Place of publishing: Nova Gorica Publisher: D. Krajnik Year of publishing: 2008 Number of pages: VI, 55 str. PID: 20.500.12556/RUNG-348  COBISS.SI-ID: 833787  UDC: 681.586 NUK URN: URN:SI:UNG:REP:77GSB2DH Publication date in RUNG: 15.10.2013 Views: 14928 Downloads: 398 Metadata:    Cite this work Plain text BibTeX EndNote XML EndNote/Refer RIS ABNT ACM Ref AMA APA Chicago 17th Author-Date Harvard IEEE ISO 690 MLA Vancouver : KRAJNIK, Domen, 2008, Izbira pretvornika signalov za laboratorijske potrebe [online]. Bachelor’s thesis. Nova Gorica : D. Krajnik. [Accessed 3 April 2025]. Retrieved from: https://repozitorij.ung.si/IzpisGradiva.php?lang=eng&id=348 Copy citation

Average score: 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 (0 votes) Your score: Voting is allowed only for logged in users. Share: Similar works from our repository: Analysis of the referral trend in ovarian cancer patients who need genetic assessment for treatment planning and presentation of new clinical pathways Summary Guidelines for Treating Ovarian Cancer and Primary Peritoneal Serous Carcinoma Rak jajčnikov in jajcevodov (Ca ovarii, Ca tubae): diagnostični algoritmi primarne bolezni Our experience with bevacizumab in the primary treatment of epithelial ovarian cancer Klinična pot genetske obravnave bolnic z epitelijskim nemucinoznim rakom jajčnikov/jajcevodov/primarnim peritonealnim seroznim karcinomom Similar works from other repositories: BRCA1/2 mutation testing from cytological samples in patients with ovarian, tubal and primary peritoneal serous cancer AKR1B1 as a prognostic biomarker of high-grade serous ovarian cancer BRCA1/2 STATUS AND CLINICO-PATHOLOGIC CHARACTERISTICS OF PATIENTS WITH DOUBLE PRIMARY BREAST AND OVARIAN CANCERAND OF PATIENTS WITH EPITHELIAL OVARIAN CANCER AKR1C3 is associated with better survival of patients with endometrial carcinomas Predictive value of the cancer stem cell related marker NANOG in ovarian serous carcinoma Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Back